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While vaccines have been the major medical intervention in human 
history that fundamentally reshaped our life-expectancy, the global 
COVID-19 pandemic reinforced public awareness about the critical 
need for further advancement of vaccine development. Multiple 
groups have published on improved and directed efforts to develop 
vaccines—efforts that are informed by the most up-to-date under-
standing of the immune system and its variability, as well as by ad-
vances in biotechnology. This century has seen a dramatic increase 
in targeted vaccines that were developed using these modern ap-
proaches to combat both infectious and non-infectious diseases.
Multiple decades of studies have spanned a wide spectrum: On 
one end, the focus is on the fundamental aspects of the adaptive 
immune system, which is responsible for initiation, progression, and 
persistence of humoral immune responses to foreign antigens (Ags); 
and the other end focuses on the development of vaccines to elicit 
desirable antibody (Ab) responses to provide protection against mul-
tiple pathogens. These immune responses consist of a carefully cho-
reographed sequence of events occurring in both time and space. 
The space, or anatomy, of the response is an essential element as it 
makes possible the myriad cellular and molecular interactions that 
must occur. The immune system has its own organs, tissues, as well 
as specialized anatomical niches within these organs and tissues 
that facilitate the growth, maturation, and development of immune 
cells. These spaces provide controlled microenvironments in which 
immune cells interact in a coordinated fashion, enabling lymphocyte 
activation, differentiation, and acquisition of effector function, as 
well as the maintenance of memory cell populations (Figure 1). One 
of those critical interactions is the communication that takes place 
between B cells and specialized CD4+ T lymphocytes, T follicular 
helper (Tfh) cells. Cognate help provided by Tfh cells is an essential 
element of robust humoral immunity. In 2000, these cells were first 
described in human tonsils1,2 and were subsequently found in other 
specialized locations within lymphoid tissues. Ensuring optimal acti-
vation of Tfh cell responses is now being considered as a promising 
approach toward developing improved vaccines. Tfh cells are just 
one of many types of specialized T helper lymphocytes that support 
the development of protective immunity. Within the B cell com-
partment, we also find specialized subsets including the following: 
plasmablasts, long- and short-lived plasma cells, and memory cells. 
Each one has their own important role to play in protection against 
foreign pathogens.
This special issue of Immunological Reviews, “B and Th cell response 
to Ag in vivo: implications for vaccine development and diseases,” in-
volves a broad and ambitious topic aimed at bringing together cur-
rent knowledge in B and Th cell immune responses (including their 
interactions) that are essential for development of long-lived humoral 
protection. The issue also includes up-to-date information about 
multiple factors that are critical for targeted vaccine development. 
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This article introduces a series of reviews covering B and Th cell response to Ag in vivo: implications for vaccine development and diseases appearing in Volume 296 of Immunological 
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The special issue will touch upon the challenges in generating broadly 
neutralizing immune responses against rapidly mutating viruses (eg, 
influenza) and dysregulation of B/Th cell responses associated with 
universal diseases such as autoimmune disease and cancer. It will 
also discuss how advancement in the vaccine field broadens its focus 
from conventional pathogens to various intervention therapies. The 
reviews included in this issue will describe multiple factors that af-
fect B and Th cell recruitment in response to Ag, B cell competition 
in germinal centers (GCs), and differentiation into memory cells and 
Ab-secreting long-lived plasma cells, persistence of the Ab-secreting 
cells, control of B cell responses by Tregs, and molecular dysregu-
lations associated with autoimmunity and B cell cancers. From the 
vaccine-focused perspective, the reviews will discuss the modula-
tion of B and Th cell immune response by virus-like particles (VLPs) 
and adjuvants, as well as the immune-response variability that oc-
curs due to aging and various genetic factors. Speaking of genetic 
factors, years of research have clearly demonstrated that allelic 
variation in the human leukocyte antigen (HLA) locus has significant 
effects on both the Ab response and the development of T helper 
activity in response to both infection and vaccination. In recognition 
of the current SARS-CoV-2 pandemic that has captured the atten-
tion of the global research community, the volume includes an article 
describing the veritable flurry of studies that have been conducted 
over a few short months to understand the role of genetic variation, 
including variation in the HLA region on SARS-COV-2 infection and 
COVID-19 clinical outcomes. That article also touches on the work 
currently being done to examine the effect of viral genetic variation 
on infection and disease severity.
The generation of broadly neutralizing Ab responses against patho-
gens requires recruitment of multiple Ag-specific B cell clones into 
T-dependent immune response that can give rise to GC-experienced 
class-switched memory B cells and long-lived plasma cells (LLPCs). 
However, recruitment of individual B cell clones into GCs depends 
on multiple factors, including Ag valency, biophysical properties and 
amount, cellular/molecular context, and duration of Ag acquisition by 
B cell and the timing of T cell help. The review by Turner et al3 attempts 
to bring these factors together in the context of spatiotemporal micro-
anatomy of B-cell activation to suggest that Ag distribution and the 
timing of the initial B-Th cell contacts may influence clonal repertoire 
of B cells recruited into primary immune response. The article also 
highlights the fact that B cells may go through more than one round of 
Ag-dependent activation in vivo and raises a few still unresolved ques-
tions in the field concerning B cell activation vs tolerance fate in vivo.
Abbott et al4 review current knowledge regarding the other critical 
factors contributing to the initiation and progression of B cell response 
to complex Ags. These factors include B cell precursor frequency, the 
F I G U R E  1   Various factors that affect humoral immune response to vaccine antigens. The figure provides an overview of the topics 
covered in the special issue: "B and Th cell response to Ags in vivo: implications for vaccine development and diseases"
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affinity of BCR: Ag binding, and Ag avidity, which can all affect the 
nature and magnitude of the GC and Ab response. Understanding how 
these factors affect the B cell response may prove useful in our ongo-
ing search for an effective HIV vaccine, a universal influenza vaccine, 
and perhaps vaccines targeting SARS-CoV-2 and other coronaviruses.
The review by Hua et al5 discusses several features that are 
critical for the initiation and progression of T-dependent and 
T-independent B cell responses to foreign Ags, with particular em-
phasis on Qβ-VLPs (bacterial phage Qβ virus-like particles with en-
capsulated single-stranded RNA). The review examines the dendritic 
cell (DCs)-centered dogma of the initial Th cell activation and infers 
that, in some cases, Ag-specific B cells may play a more important 
or even more dominant role than DCs as Ag-presenting cells for Th 
cells (e.g., following immunization with viral-like particles [Qβ-VLPs] 
or with inactivated viruses, as well as in the course of progressive 
autoimmune diseases). The review also addresses the role of TLR-
signaling in T-independent proliferation of B cells, magnitude and 
duration of GC responses, and in autoimmunity.
The role of cognate B-T cell interactions during initiation and 
progression of T-dependent B cell responses is rendered critical. The 
review by Biram et al6 outlines what is known about the temporal 
dynamics of B-Th cell encounters and their molecular communica-
tion, Tfh that are critical for GCs, and the principles underlying GC 
B cells affinity maturation and selection. The review touches on the 
currently evolving understanding of B cell responses at mucosal 
surfaces and in peyer's patches (PP), including T-independent IgA 
responses to commensal bacteria and rotaviruses, extensive B cell 
proliferation in subepithelial dome of PP, and atypical non-cognate 
T cell help that supports GCs B cells in PP in parallel to the conven-
tional cognate Tfh-cell driven selection.
While Tfh cell help to GC B cells, which undergo rapid somatic 
hypermutation, is critical for selection of B cell clones with high affinity 
to Ag, this process promotes lymphomagenesis and has been known 
to lead to cancer. The review by Minz et al7 takes a pointed view re-
garding the molecular mechanisms driving Tfh and GC B cell communi-
cation in the off-target support of various GC-originated malignancies, 
such as follicular lymphomas, GC B cell-diffuse large B cell lymphomas, 
and Burkitt lymphomas. The review provides analysis of the molecu-
lar players and signaling pathways responsible for Tfh cells-mediated 
support of GC B cells, discusses them in the context of malignancy-as-
sociated mutations and suggests potential therapeutic approaches to 
disable Tfh-GC B cells communication to avert lymphomagenesis.
The major target of vaccination is development of memory B 
cells (Bmem), which should be reactivated upon infection if preexist-
ing Ab titers are insufficient or suboptimal for pathogen recognition 
and removal. The heterogeneous populations of Bmem cells in terms 
of their origin, trafficking, and fate are elucidated in the review by 
Dhenni et al.8 It also provides a comprehensive overview of memory 
B cell subsets present at various anatomical locations and discusses 
the microanatomy of Ag and T cell help acquisition by Bmem cells 
that is very distinct from naïve B cells. Finally, the review describes 
atypical and autoreactive Bmem cells and their surfacing role in mul-
tiple autoimmune diseases.
Another major focus in the vaccine field is generation of LLPCs; 
however, while immunizations usually trigger plasma cell (PC) re-
sponse, variable success is noted in terms of PC persistence. The 
review by Robinson et al9 provides an overview of the up-to-date 
knowledge about the intrinsic and extrinsic determinants of PC sur-
vival and persistence in the bone marrow (BM). The review covers the 
origins of PC development, PC homing and adhesion in the BM, and 
their metabolic regulation. In addition, it describes various cells, mole-
cules, and processes that support survival of PCs in the BM niches in a 
master transcription regulator Mcl1-dependent fashion. Finally, the re-
view discusses various models of PC turnover in the BM and suggests 
an important role of inflammation for this process.
While vaccine responses should lead to development of memory B 
cells and LLPCs, triggering B cell responses may also lead to undesirable 
effects, such as elevated production of IgE class-switched or autoreac-
tive Abs, which may contribute to allergic reactions and autoimmunity. 
Tregs, particularly their subset called follicular regulatory T cells (Tfr), 
have been implicated as the cells controlling these processes. The re-
view by Wing et. al10 provides a detailed overview of Tregs’ functions 
and heterogeneity and of the Treg/ Tfr -mediated control of B cells and 
Ab responses. It also describes transcriptional regulation of Tfr devel-
opment, Tfr localization, specificity, their role in affinity maturation and 
viral infections, and discusses perspectives that target Tfrs in therapies 
to improve immune responses to vaccines and to avert allergies.
The next article in this issue focuses on efforts to create more 
effective (and broadly reactive) vaccine responses against influenza. 
Fukuyama et al11 argue that Abs targeting conserved epitopes in 
the stem region of the hemagglutinin protein offer broad protection 
against antigenically divergent influenza strains. Mechanistic-based 
vaccination strategies that lead to the formation of memory B cell 
populations producing broadly reactive Abs may also be applicable 
to other viral pathogens.
The article by Frasca et al12 shifts our attention to the effect of 
age on immune response to vaccination and infection. They dissect 
the molecular and cellular mechanisms contributing to immunosenes-
cence, with particular attention paid to defective interactions between 
T helper cells and B cells and alterations in the microenvironment. One 
important contributor to immunosenescence is believed to be the ac-
cumulation of immune cells with a senescence-associated phenotype. 
The impact of these cells on immune function is highlighted. Age-
related changes in metabolic activity are also enumerated, and their 
impact on immune dysregulation is also discussed.
Mohsen et al13 provide a thought-provoking review regarding 
the design of vaccine Ags, the delivery of those Ags, and the dynam-
ics of the response. They explore these concepts in the context of 
highly repetitive virus-like particle Ags, where size and other char-
acteristics can be manipulated to fine-tune Ag delivery to lymphoid 
tissues, thereby shaping desired immune responses.
The next article, by Schijns et al,14 also deals with the modulation 
of immune function, but approaches the issue from two different 
standpoints: adjuvant usage and therapeutic vaccination. The au-
thors contend that therapeutic vaccination has untapped potential 
due to the large number of chronic health conditions with immune 
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components. The article begins with a discussion of the indications 
for therapeutic vaccination and segues into a review of the adju-
vants and innate immune responses that may be harnessed for op-
timal vaccine efficacy. There is a careful consideration of elements 
necessary for the induction of not only humoral immunity, but also 
cell-mediated responses, which are all too often ignored or mini-
mized during discussions of vaccine efficacy.
Knight et.al15 provide a detailed overview of the difficulties fac-
ing the immune response to influenza, covering: immunodominance, 
viral mutation of both the hemagglutinin and neuraminidase proteins 
to avoid immune recognition, and immunologic imprinting and origi-
nal antigenic sin. The authors describe the effects these phenomena 
have on B cell responses to infection and vaccination, the mecha-
nisms behind those effects, and how to use this knowledge to de-
velop vaccines eliciting protective immune responses with broad or 
universal influenza strain reactivity.
The final article in this issue focuses on genetic variation and im-
mune response to infection and vaccination. This is a topic that has 
been extensively reviewed in the scientific literature; because of this, 
Ovsyannikova et al16 highlighted the studies focusing on human coro-
naviruses, including the four seasonal coronaviruses, SARS-CoV, MERS-
CoV, and SARS-CoV-2. In the few months since the COVID-19 pandemic 
began, there has been an explosion of published SARS-CoV-2-specific 
literature on PubMed and preprint servers, with well over 1000 manu-
scripts becoming available every week. It will not surprise our readers 
to see that this has included a number of reports characterizing viral ge-
netic variation and assessing the impact of both viral and host genetics 
on infection and disease severity. We fully expect that these intensified 
research activities will continue well into the future and will provide a 
wealth of information regarding this novel pathogen. This work will also 
foster an increased understanding of the dynamic interactions of the 
immune system in the development of protective immunity.
Collectively, these articles will provide the reader with insights 
into T and B cell interactions during the development of immune re-
sponses to infection and vaccination. This issue also highlights the 
progress that has been made in understanding the intricate details of 
immune response and how those insights are currently being used to 
inform vaccine development. Each article outlines major areas cur-
rently under investigation that are poised to deliver the next set of 
advances in our understanding of how immunity develops.
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